{"data":[{"accessionNo":"0000312069-26-000206","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001453687","issuerName":"CARTESIAN THERAPEUTICS INC","ticker":"RNAC","cusip":"816212302","securityClass":"COMMON-STOCK","eventDate":"2026-06-30","reportingPerson":"Barclays PLC","reportingCik":null,"personType":"HC","sharesOwned":1760326,"percentOfClass":5.99,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0000019617-26-000272","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001453687","issuerName":"Cartesian Therapeutics, Inc.","ticker":"RNAC","cusip":"816212302","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"JPMORGAN CHASE & CO.","reportingCik":null,"personType":"HC","sharesOwned":1486252,"percentOfClass":4.8,"filedAt":"2026-07-22","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0000315066-26-001134","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001453687","issuerName":"CARTESIAN THERAPEUTICS INC","ticker":"RNAC","cusip":"816212302","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":799743,"percentOfClass":3,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0000315066-26-001134","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001453687","issuerName":"CARTESIAN THERAPEUTICS INC","ticker":"RNAC","cusip":"816212302","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":799743,"percentOfClass":3,"filedAt":"2026-05-06","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0001193125-26-140633","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001453687","issuerName":"Cartesian Therapeutics, Inc.","ticker":"RNAC","cusip":"816212104","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Murat Kalayoglu","reportingCik":"0002000002","personType":"IN","sharesOwned":5833971,"percentOfClass":19.9,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0001193125-26-140633","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001453687","issuerName":"Cartesian Therapeutics, Inc.","ticker":"RNAC","cusip":"816212104","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Seven One Eight Three Four Irrevocable Trust","reportingCik":"0002000959","personType":"OO","sharesOwned":5313261,"percentOfClass":18.1,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0001193125-26-140633","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001453687","issuerName":"Cartesian Therapeutics, Inc.","ticker":"RNAC","cusip":"816212104","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Elizabeth Hoge","reportingCik":"0002000987","personType":"HC,IN","sharesOwned":5313261,"percentOfClass":18.1,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0001193125-26-140633","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001453687","issuerName":"Cartesian Therapeutics, Inc.","ticker":"RNAC","cusip":"816212104","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Sinan Kalayoglu","reportingCik":null,"personType":"HC,IN","sharesOwned":5313261,"percentOfClass":18.1,"filedAt":"2026-04-02","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0001642575-26-000003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001453687","issuerName":"Cartesian Therapeutics, Inc.","ticker":"RNAC","cusip":null,"securityClass":"Common Stock","eventDate":"2026-03-09","reportingPerson":"Squarepoint Ops LLC","reportingCik":null,"personType":"IA","sharesOwned":2209601,"percentOfClass":8.3,"filedAt":"2026-03-13","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0001642575-26-000003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001453687","issuerName":"Cartesian Therapeutics, Inc.","ticker":"RNAC","cusip":null,"securityClass":"Common Stock","eventDate":"2026-03-09","reportingPerson":"Squarepoint Capital LLP","reportingCik":null,"personType":"IA","sharesOwned":2209601,"percentOfClass":8.3,"filedAt":"2026-03-13","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0001642575-26-000003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001453687","issuerName":"Cartesian Therapeutics, Inc.","ticker":"RNAC","cusip":null,"securityClass":"Common Stock","eventDate":"2026-03-09","reportingPerson":"Squarepoint Operations Private Limited","reportingCik":null,"personType":"IA","sharesOwned":2209601,"percentOfClass":8.3,"filedAt":"2026-03-13","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0001642575-26-000003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001453687","issuerName":"Cartesian Therapeutics, Inc.","ticker":"RNAC","cusip":null,"securityClass":"Common Stock","eventDate":"2026-03-09","reportingPerson":"Squarepoint (DIFC) Ltd","reportingCik":null,"personType":"IA","sharesOwned":2209601,"percentOfClass":8.3,"filedAt":"2026-03-13","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0001642575-26-000003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001453687","issuerName":"Cartesian Therapeutics, Inc.","ticker":"RNAC","cusip":null,"securityClass":"Common Stock","eventDate":"2026-03-09","reportingPerson":"Squarepoint Master Fund Limited","reportingCik":null,"personType":"OO","sharesOwned":2178652,"percentOfClass":8.2,"filedAt":"2026-03-13","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0001642575-26-000003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001453687","issuerName":"Cartesian Therapeutics, Inc.","ticker":"RNAC","cusip":null,"securityClass":"Common Stock","eventDate":"2026-03-09","reportingPerson":"Squarepoint Core Master Fund Limited","reportingCik":null,"personType":"OO","sharesOwned":30949,"percentOfClass":0.1,"filedAt":"2026-03-13","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0000315066-26-000393","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001453687","issuerName":"CARTESIAN THERAPEUTICS INC","ticker":"RNAC","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":1366989,"percentOfClass":5.3,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0000315066-26-000393","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001453687","issuerName":"CARTESIAN THERAPEUTICS INC","ticker":"RNAC","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":1366989,"percentOfClass":5.3,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0000315066-25-002709","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001453687","issuerName":"CARTESIAN THERAPEUTICS INC","ticker":"RNAC","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":2155783,"percentOfClass":8.3,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"},{"accessionNo":"0000315066-25-002709","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001453687","issuerName":"CARTESIAN THERAPEUTICS INC","ticker":"RNAC","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":2155783,"percentOfClass":8.3,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/rnac"}],"updatedAt":"2026-11-05T11:35:11.614Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/rnac","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}